Paul-Olivier Rouzaire (Paul Rouzaire)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 49

Top Topics

Sickle Cell Disease

Gene Expression

Top Venues

Cancer immunology, immunotherapy : CII

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lucie Blandin, Jonathan Visentin, Gwendaline Guidicelli, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DRB3*02:194 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Marine Cargou, Elodie Wojciechowski, Richard Lemal, Paul-Olivier Rouzaire
Characterisation of the novel HLA-DRB4*01:182 allele by sequencing-based typing. HLA 104 (1) (2024)
Lucie Blandin, Jonathan Visentin, Elodie Wojciechowski, Richard Lemal, Paul-Olivier Rouzaire
Characterisation of the novel HLA-DQA1*05:112 allele by sequencing-based typing. HLA 104 (1) (2024)
Richard Lemal, Lucie Blandin, Charlotte Uro-Coste, Carole Philipponnet, Etienne Geoffroy, Anne-Elisabeth Heng, Cyril Garrouste, Paul-Olivier Rouzaire
Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review. HLA 103 (4) (2024)
Richard Lemal, Lucie Blandin, Charlotte Uro-Coste, Carole Philipponnet, Etienne Geoffroy, Anne-Elisabeth Heng, Cyril Garrouste, Paul-Olivier Rouzaire
Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review. HLA 103 (4) (2024)
Lucie Blandin, Marine Cargou, Gwendaline Guidicelli, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPB1*1516:01 allele by sequencing-based typing. HLA 103 (2) (2024)
Lucie Blandin, Mamy Ralazamahaleo, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-A*32:177 allele by sequencing-based typing. HLA 103 (2) (2024)
Lucie Blandin, Marion Duclaut, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPA1*02:122 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Marion Duclaut, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPA1*02:122 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Gwendaline Guidicelli, Elodie Wojciechowski, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DQB1*02:01:01:21Q allele by sequencing-based typing. HLA 103 (4) (2024)
Lucie Blandin, Mamy Ralazamahaleo, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterisation of the novel HLA-DRB1*04:379N allele by sequencing-based typing. HLA 104 (1) (2024)
Lucie Blandin, Mamy Ralazamahaleo, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-B*14:122 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Mamy Ralazamahaleo, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-B*14:122 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Marine Cargou, Elodie Wojciechowski, Richard Lemal, Paul-Olivier Rouzaire
Characterisation of the novel HLA-DRB4*01:182 allele by sequencing-based typing. HLA 104 (1) (2024)
Lucie Blandin, Marine Cargou, Gwendaline Guidicelli, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPB1*1516:01 allele by sequencing-based typing. HLA 103 (2) (2024)
Lucie Blandin, Mamy Ralazamahaleo, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-A*32:177 allele by sequencing-based typing. HLA 103 (2) (2024)
Lucie Blandin, Jonathan Visentin, Gwendaline Guidicelli, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DRB3*02:194 allele by sequencing-based typing. HLA 103 (1) (2024)
Lucie Blandin, Jonathan Visentin, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPA1*02:115 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Gwendaline Guidicelli, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DRB1*13:03:13 allele by sequencing-based typing. HLA (2023)
Aurore Dougé, Cyrielle Vituret, Valérie Carraro, Laurent Parry, Cécile Coudy-Gandilhon, Richard Lemal, Lydie Combaret, Anne-Catherine Maurin, Julien Averous, Céline Jousse, Jacques-Olivier Bay, Pierre Verrelle, Pierre Fafournoux, Alain Bruhat, Paul-Olivier Rouzaire
Temporal regulation of transgene expression controlled by amino acid availability in human T cells. HLA (2023)
Lucie Blandin, Jonathan Visentin, Marion Duclaut, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-C*16:98:02 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Marine Cargou, Elodie Wojciechowski, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-B*51:384 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Jean Milhes, Nicolas Congy-Jolivet, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DRB3*02:193 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Marine Cargou, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DRB1*11:324 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Jonathan Visentin, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DQA1*01:64:02 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Jonathan Visentin, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-B*39:06:09 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Elodie Wojciechowski, Mamy Ralazamahaleo, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DPA1*01:03:51 allele by sequencing-based typing. HLA (2023)
Lucie Blandin, Mamy Ralazamahaleo, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-B*08:312 allele by sequencing-based typing. HLA (2023)
Aurore Dougé, Nathan El-Ghazzi, Richard Lemal, Paul-Olivier Rouzaire
Adoptive T cells therapy in solid tumors: state-of-the art, current challenges, and upcoming improvements. Molecular cancer therapeutics (2023)
Lucie Blandin, Jonathan Visentin, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-C*07:1023 allele by sequencing-based typing. HLA 100 (6) (2022)
Lucie Blandin, Gwendaline Guidicelli, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-B*15:01:01:65Q allele by sequencing-based typing. HLA (2022)
Lucie Blandin, Gwendaline Guidicelli, Elodie Wojciechowski, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-C*03:606 allele by sequencing-based typing. HLA 100 (6) (2022)
Lucie Blandin, Elodie Wojciechowski, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DQB1*05:01:47 allele by sequencing-based typing. HLA (2022)
Lucie Blandin, Jonathan Visentin, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-A*01:419 allele by sequencing-based typing. HLA 100 (6) (2022)
Lucie Blandin, Mamy Ralazamahaleo, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-C*06:311 allele by sequencing-based typing. HLA 97 (6) (2021)
Lucie Blandin, Aurore Dougé, Amandine Fayard, Jacques-Olivier Bay, Guillaume Berlie, Bruno Pereira, Richard Lemal, Paul-Olivier Rouzaire
Platelet transfusion refractoriness and anti-HLA immunization. Transfusion 61 (6) (2021)
Lucie Blandin, Marine Cargou, Elodie Wojciechowski, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-A*29:02:38 allele by sequencing-based typing. HLA (2021)
Lucie Blandin, Laura Blouin, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-DPB1*1139:01 allele by sequencing-based typing. HLA 98 (3) (2021)
Lucie Blandin, Jonathan Visentin, Gwendaline Guidicelli, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-B*14:01:13 allele by sequencing-based typing. HLA 98 (2) (2021)
Lucie Blandin, Marine Cargou, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DQA1*01:01:10 allele by sequencing-based typing. HLA 98 (4) (2021)
Lucie Blandin, Gwendaline Guidicelli, Laura Blouin, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-C*05:01:58 allele by sequencing-based typing. HLA 98 (2) (2021)
Lucie Blandin, Mamy Ralazamahaleo, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DQA1*05:01:07 allele by sequencing-based typing. HLA (2021)
Lucie Blandin, Jonathan Visentin, Gwendaline Guidicelli, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-B*56:76 allele by sequencing-based typing. HLA 98 (1) (2021)
Lucie Blandin, Jonathan Visentin, Mamy Ralazamahaleo, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-C*04:451 allele by sequencing-based typing. HLA 98 (5) (2021)
Lucie Blandin, Jonathan Visentin, Marine Cargou, Richard Lemal, Paul-Olivier Rouzaire
Characterization of the novel HLA-A*26:01:66 allele by sequencing-based typing. HLA 97 (6) (2021)
Lucie Blandin, Marine Cargou, Mamy Ralazamahaleo, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-B*18:204 allele by sequencing-based typing. HLA 98 (2) (2021)
Steve Genebrier, Paul-Olivier Rouzaire, Emeric Texeraud, Gerald Bertrand, Virginie Renac
Characterization of the novel HLA-DQA1*05:19 allele by next-generation sequencing. HLA 98 (3) (2021)
Lucie Blandin, Gwendaline Guidicelli, Marine Cargou, Paul-Olivier Rouzaire, Richard Lemal
Characterization of the novel HLA-DPA1*01:03:34 allele by sequencing-based typing. HLA (2021)
Jacques Rouanet, Valentin Benboubker, Hussein Akil, Ana Hennino, Philippe Auzeloux, Sophie Besse, Bruno Pereira, Solène Delorme, Sandrine Mansard, Michel D'Incan, Françoise Degoul, Paul-Olivier Rouzaire
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer immunology, immunotherapy : CII 69 (10) (2020)